Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Connexins | 3 | 2019 | 356 | 1.540 |
Why?
|
Keratitis | 2 | 2019 | 239 | 1.010 |
Why?
|
Ichthyosis | 3 | 2024 | 58 | 0.860 |
Why?
|
Turner Syndrome | 2 | 2021 | 129 | 0.840 |
Why?
|
Genes, Lethal | 1 | 2019 | 224 | 0.620 |
Why?
|
Respiratory Tract Fistula | 1 | 2018 | 25 | 0.610 |
Why?
|
Protein Structure, Quaternary | 1 | 2019 | 423 | 0.590 |
Why?
|
Failure to Thrive | 1 | 2018 | 138 | 0.580 |
Why?
|
Dermatology | 3 | 2023 | 907 | 0.570 |
Why?
|
Skin Diseases | 2 | 2016 | 1088 | 0.490 |
Why?
|
Cosmetics | 2 | 2016 | 102 | 0.480 |
Why?
|
Deafness | 1 | 2018 | 460 | 0.450 |
Why?
|
Congenital Abnormalities | 1 | 2018 | 704 | 0.430 |
Why?
|
Oximes | 1 | 2015 | 305 | 0.420 |
Why?
|
Keratosis, Seborrheic | 1 | 2012 | 31 | 0.400 |
Why?
|
Paraneoplastic Syndromes | 1 | 2012 | 156 | 0.360 |
Why?
|
Vitiligo | 1 | 2012 | 96 | 0.360 |
Why?
|
Imidazoles | 1 | 2015 | 1162 | 0.310 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2015 | 1140 | 0.300 |
Why?
|
Complementary Therapies | 1 | 2012 | 487 | 0.290 |
Why?
|
Ichthyosis, Lamellar | 1 | 2024 | 11 | 0.230 |
Why?
|
Smad4 Protein | 1 | 2024 | 193 | 0.210 |
Why?
|
Cosmetic Techniques | 2 | 2016 | 149 | 0.200 |
Why?
|
Alopecia Areata | 1 | 2024 | 129 | 0.190 |
Why?
|
Acne Vulgaris | 2 | 2024 | 352 | 0.190 |
Why?
|
Nevus, Halo | 1 | 2020 | 5 | 0.180 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 19 | 0.170 |
Why?
|
Tinea Capitis | 1 | 2019 | 16 | 0.170 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2020 | 40 | 0.170 |
Why?
|
Models, Molecular | 2 | 2019 | 5379 | 0.160 |
Why?
|
Pemphigus, Benign Familial | 1 | 2018 | 8 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5696 | 0.150 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2019 | 164 | 0.150 |
Why?
|
Thermodynamics | 1 | 2019 | 580 | 0.140 |
Why?
|
Protein Stability | 1 | 2019 | 577 | 0.140 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 729 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3646 | 0.130 |
Why?
|
Antimalarials | 1 | 2023 | 913 | 0.130 |
Why?
|
Syringoma | 1 | 2016 | 8 | 0.130 |
Why?
|
Fibroadenoma | 1 | 2016 | 40 | 0.130 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 385 | 0.120 |
Why?
|
Naltrexone | 1 | 2018 | 319 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 622 | 0.120 |
Why?
|
Ectodermal Dysplasia | 1 | 2016 | 106 | 0.120 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1137 | 0.120 |
Why?
|
Crystallography, X-Ray | 1 | 2019 | 1947 | 0.120 |
Why?
|
Sweat Gland Neoplasms | 1 | 2016 | 110 | 0.120 |
Why?
|
Molecular Structure | 1 | 2018 | 1885 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1087 | 0.110 |
Why?
|
Narcotic Antagonists | 1 | 2018 | 590 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.100 |
Why?
|
Epidermis | 1 | 2016 | 538 | 0.100 |
Why?
|
Aromatherapy | 1 | 2012 | 4 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1050 | 0.100 |
Why?
|
Antirheumatic Agents | 1 | 2022 | 1365 | 0.100 |
Why?
|
Medicine, Ayurvedic | 1 | 2012 | 37 | 0.100 |
Why?
|
Biological Products | 1 | 2021 | 942 | 0.100 |
Why?
|
Naphthoquinones | 1 | 2012 | 61 | 0.100 |
Why?
|
Medicine, Chinese Traditional | 1 | 2012 | 73 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11868 | 0.090 |
Why?
|
Quality of Life | 2 | 2018 | 13462 | 0.090 |
Why?
|
Clothing | 1 | 2012 | 95 | 0.090 |
Why?
|
Humans | 25 | 2024 | 765968 | 0.090 |
Why?
|
Mutation | 4 | 2024 | 30198 | 0.090 |
Why?
|
Psychotropic Drugs | 1 | 2016 | 879 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2020 | 5849 | 0.090 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 999 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4209 | 0.080 |
Why?
|
Comorbidity | 1 | 2023 | 10563 | 0.080 |
Why?
|
Genotype | 2 | 2024 | 13024 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16721 | 0.080 |
Why?
|
Education, Medical | 1 | 2020 | 1746 | 0.080 |
Why?
|
Analgesics | 1 | 2015 | 1060 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4622 | 0.070 |
Why?
|
Acupuncture Therapy | 1 | 2012 | 466 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2012 | 966 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 81514 | 0.070 |
Why?
|
Massachusetts | 3 | 2024 | 8875 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2054 | 0.060 |
Why?
|
Male | 11 | 2024 | 363698 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8703 | 0.060 |
Why?
|
Facies | 1 | 2024 | 223 | 0.050 |
Why?
|
Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
Cryptorchidism | 1 | 2024 | 152 | 0.050 |
Why?
|
Hand Deformities, Congenital | 1 | 2024 | 175 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3105 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Erythema | 1 | 2024 | 262 | 0.050 |
Why?
|
Psychometrics | 1 | 2012 | 3062 | 0.050 |
Why?
|
Middle Aged | 8 | 2024 | 223009 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5719 | 0.050 |
Why?
|
Adult | 10 | 2024 | 223044 | 0.050 |
Why?
|
Infant | 2 | 2024 | 36386 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26318 | 0.040 |
Why?
|
Aminoquinolines | 1 | 2020 | 102 | 0.040 |
Why?
|
Hospitals, General | 1 | 2024 | 802 | 0.040 |
Why?
|
Growth Disorders | 1 | 2024 | 633 | 0.040 |
Why?
|
Hydroxychloroquine | 1 | 2023 | 431 | 0.040 |
Why?
|
Young Adult | 5 | 2024 | 59889 | 0.040 |
Why?
|
Female | 9 | 2024 | 396112 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 163 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2018 | 26346 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2615 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15880 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1648 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2334 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 88835 | 0.030 |
Why?
|
Aged | 5 | 2021 | 171117 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3344 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2226 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2024 | 1915 | 0.020 |
Why?
|
Psoriasis | 1 | 2020 | 919 | 0.020 |
Why?
|
Neoplasms | 1 | 2021 | 22340 | 0.020 |
Why?
|
Foot | 1 | 2016 | 573 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2018 | 65188 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13648 | 0.020 |
Why?
|
Crohn Disease | 1 | 2024 | 2283 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3050 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2024 | 2429 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3426 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42500 | 0.020 |
Why?
|
Child | 3 | 2024 | 80564 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2020 | 3615 | 0.020 |
Why?
|
Students, Medical | 1 | 2020 | 1959 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22223 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20124 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74840 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 3278 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9347 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168764 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59489 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39193 | 0.010 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_